CRBU logo

CRBUCaribou Biosciences Inc

$1.71
$0.045
(2.71%)
Today
Updated: 09:49 AM EDT
EarningsAug 12
Mkt Cap$164.64M
Vol100,802.00
News
all
press releases
Caribou Biosciences (CRBU) Gets A Higher Target As Confidence In Its Pipeline Grows
Caribou Biosciences (CRBU) Gets A Higher Target As Confidence In Its Pipeline Grows...
Yahoo! Finance: News
News Placeholder
More News
News Placeholder
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Caribou Biosciences (CRBU) delivered earnings and revenue surprises of +21.81% and -4.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates
Qiagen (QGEN) delivered earnings and revenue surprises of -1.23% and -0.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Caribou Biosciences (NASDAQ:CRBU) Stock Price Down 2.3% - Here's Why
Caribou Biosciences (NASDAQ:CRBU) Stock Price Down 2.3% - What's Next...
MarketBeat
News Placeholder
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Here is how Agilon Health (AGL) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.
Zacks
News Placeholder
Three Best Genomics Stocks for Your Portfolio in 2026
Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.
Zacks
News Placeholder
Caribou Biosciences' (CRBU) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated a "buy" rating and set a $9.00 price target on shares of Caribou Biosciences in a research report on Tuesday...
MarketBeat
News Placeholder
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock?
Alpha Cognition Inc. (ACOG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
News Placeholder
Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?
Sarepta Therapeutics (SRPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks
News Placeholder
Caribou Biosciences (NASDAQ:CRBU) Stock Rating Upgraded by Truist Financial
Truist Financial raised shares of Caribou Biosciences to a "strong-buy" rating in a research report on Wednesday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.